CryptoProwl
Wed, April 1, 2026 astatine 8:35 AM CDT 1 min read
Moody’s (NYSE: $MCO) has issued its archetypal standing connected a Bitcoin-backed (CRYPTO: $BTC) bond.
The New Hampshire Business Finance Authority is acceptable to contented what appears to beryllium the archetypal professionally rated Bitcoin-backed bond, marking yet different measurement toward integrating cryptocurrencies into accepted finance.
The enslaved has received a “Ba2 rating” from Moody’s, a starring U.S. recognition standing agency. That Ba2 standing is 2 notches beneath what’s considered concern grade.
More From Cryptoprowl:
-
Eightco Secures $125 Million Investment From Bitmine And ARK Invest, Shares Surge
-
Blockchain Projects Decline 75% As Developers Shift To A.I.
-
Stanley Druckenmiller Says Stablecoins Could Reshape Global Finance
-
New York Stock Exchange Invests $600 Million In Polymarket
The enslaved volition beryllium issued done the Business Finance Authority of the State of New Hampshire and is backed by Bitcoin held arsenic collateral, according to a property merchandise announcing the rating.
“The Rated Bonds volition beryllium collateralized by a loan… backed by Bitcoin, a integer currency,” Moody’s said successful the quality release.
Moody’s added that its standing reflects “risks associated with the transaction's collateral, operation and operation,” notably Bitcoin’s volatility.
Additionally, Moody’s stressed that nary nationalist funds are astatine hazard from the Bitcoin-backed enslaved merchantability by the State of New Hampshire.
Analysts accidental that the Ba2 standing places the enslaved successful speculative-grade territory, but signals to markets that recognition standing agencies are processing frameworks for crypto-backed assets.
The woody arrives arsenic institutions trial ways to usage Bitcoin beyond trading oregon treasury holdings.
The U.S. Labor Department precocious projected a regularisation alteration that volition unfastened 401(k) status plans to cryptocurrencies specified arsenic Bitcoin.
MCO banal has declined 7% implicit the past 12 months to commercialized astatine $436.25 U.S. per share.

1 day ago
3



.png)

English (CA) ·
English (US) ·
Spanish (MX) ·